Risk
of TB-associated Immune Reconstitution Disease Is High in South African
Patients Initiating Antiretroviral Therapy with Low Baseline CD4 Cell Counts
- 3/16/07
African
DART Study Confirms Risk of Strategic Treatment Interruption
- 8/25/06
Response
to Antiretroviral Therapy and Survival in HIV/HCV and HIV/HBV Coinfected Patients
in Asia
- 8/25/06
New
AIDS Pill to Treat People in Poor Countries: AZT + 3TC + Nevirapine
-
7/07/06
Simple
Regimens Are Highly Effective in Developing World - 2/28/06
Enrolling
Women into HIV Preventive Vaccine Trials: An Ethical Imperative but a Logistical
Challenge - 2/28/06
Thailand
and China To Launch Herbal Drug for People with HIV - 1/13//06
Non
European HIV Patients on HAART in a Dutch Cohort Show Increased Risk of Early
Virological Failure
- 9/23/05
Gilead
Reduces Prices in Developing Countries for Tenofovir and for Emtricitabine
and Tenofovir Fixed-dose Combination Tablet -
9/02/05
AIDS
Treatment Goal for Developing Countries Won't Be Met -
7/01/05
Heterosexual
HIV Epidemic Possible in China -
6/27/05
Immune Reconstitution
Disease Is Associated with Mycobacterial Infections in HIV Patients Receiving
Antiretrovirals
-
6/08/05
Early
Exclusive Breastfeeding Significantly Reduces the Risk of HIV Transmission and
Increases HIV-free Survival of Infants -
4/11/05
C K Mutuluuza and others. Short-term
Virologic Response to a Triple Nucleoside/Nucleotide Analogue Regimen in Adults
with HIV Infection in Africa within the DART Trial.
Abstract
22.  -
3/28/05
Global
Campaign Against Tuberculosis Makes Headway, but AIDS and Africa Have Big Problems
- 3/25/05
Brazil
Takes Step Toward Breaking AIDS Patents -
3/18/05
AIDS
Pioneer Luc Montagnier Calls for Focus on 'Therapeutic' Vaccine -
3/14/05
|
 |
